Saeed Solali

Saeed Solali


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Genes & Diseases
Verified
Journal Article
Open access
MFMasoumeh Fardi
Masoumeh Fardi
SSSaeed Solali
Saeed Solali
MHMajid Farshdousti Hagh
Majid Farshdousti Hagh
Epigenetic, along with genetic mechanisms, is essential for natural evolution and maintenance of specific patterns of gene expression in mammalians. Global epigenetic variation is inherited somatically and unlike genetic variation, it is dynamic and reversible. They are somatically associated with known genetic variations. Recent studies indicate the broad role of epigenetic mechanisms in the initiation and development of cancers, that they are including DNA methylation, histone modifications, nucleosomes changes, non-coding RNAs. The reversible nature of epigenetic changes has led to the emergence of novel epigenetic therapeutic approaches, so that several types of these medications have been approved by the FDA so far. In this review, we discuss the concept of epigenetic changes in diseases, especially cancers, the role of these changes in the onset and progression of cancers and the potential of using this knowledge in designing novel therapeutic strategies.

17 February 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
MFMasoumeh Fardi
Masoumeh Fardi
MAMohammadreza Alivand
Mohammadreza Alivand
Behzad BaradaranBehzad Baradaran
Behzad Baradaran
MHMajid Farshdousti Hagh
Majid Farshdousti Hagh
SSSaeed Solali
Saeed Solali

9 May 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
AHAli Hassanzadeh
Ali Hassanzadeh
MHMajid Farshdousti Hagh
Majid Farshdousti Hagh
MAMohammad Reza Alivand
Mohammad Reza Alivand
AAAli Akbar Movassaghpour Akbari
Ali Akbar Movassaghpour Akbari
KAKarim Shams Asenjan
Karim Shams Asenjan
SSSaeed Solali
Saeed Solali

1 January 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
MRMina Rahmani
Mina Rahmani
MTMehdi Talebi
Mehdi Talebi
MHMajid Farshdousti Hagh
Majid Farshdousti Hagh
AFAbbas A.HOsseinpour Feizi
Abbas A.HOsseinpour Feizi
SSSaeed Solali
Saeed Solali
DNA methylation is a dynamic process influencing gene expression by altering either coding or non-coding loci. Despite advances in treatment of Acute Lymphoblastic Leukemia (ALL); relapse occurs in approximately 20% of patients. Nowadays, epigenetic factors are considered as one of the most effective mechanisms in pathogenesis of malignancies. These factors are reversible elements which can be potentially regarded as therapy targets and disease prognosis. DNA methylation, which primarily serves as transcriptional suppressor, mostly occurs in CpG islands of the gene promoter regions. This was shown as a key epigenetic factor in inactivating various tumor suppressor genes during cancer initiation and progression. We aimed to review methylation status of key genes involved in hematopoietic malignancies such as IKZF1, CDKN2B, TET2, CYP1B1, SALL4, DLC1, DLX family, TP73, PTPN6, and CDKN1C; and their significance in pathogenesis of ALL. The DNA methylation alterations in promoter regions of the genes have been shown to play crucial roles in tumorigenesis. Methylation -based inactivation of these genes has also been reported as associated with prognosis in acute leukemia. In this review, we also addressed the association of gene expression and methylation pattern in ALL patients.

1 February 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
ANAdel Naimi
Adel Naimi
AMAli Akbar Movassaghpour
Ali Akbar Movassaghpour
MHMajid Farshdousti Hagh
Majid Farshdousti Hagh
MTMehdi Talebi
Mehdi Talebi
AEAtefeh Entezari
Atefeh Entezari
SSSaeed Solali
Saeed Solali

7 September 2020 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
EHElham Hosseinzadeh
Elham Hosseinzadeh
AHAli Hassanzadeh
Ali Hassanzadeh
FMFaroogh Marofi
Faroogh Marofi
MAMohammad Reza Alivand
Mohammad Reza Alivand
SSSaeed Solali
Saeed Solali
: As cancers are one of the most important causes of human morbidity and mortality worldwide, researchers try to discover novel compounds and therapeutic approaches to decrease survival of cancer cells, angiogenesis, proliferation and metastasis. In the last decade, use of special phytochemical compounds and flavonoids was reported to be an interesting and hopeful tactic in the field of cancer therapy. Flavonoids are natural polyphenols found in plant, fruits, vegetables, teas and medicinal herbs. Based on reports, over 10,000 flavonoids have been detected and categorized into several subclasses, including flavonols, anthocyanins, flavanones, flavones, isoflavones and chalcones. It seems that the anticancer effect of flavonoids is mainly due to their antioxidant and anti inflammatory activities and their potential to modulate molecular targets and signaling pathways involved in cell survival, proliferation, differentiation, migration, angiogenesis and hormone activities. The main aim of this review is to evaluate the relationship between flavonoids consumption and cancer risk, and discuss the anti-cancer effects of these natural compounds in human cancer cells. Hence, we tried to collect and revise important recent in vivo and in vitro researches about the most effective flavonoids and their main mechanisms of action in various types of cancer cells.